This significant correlation between circulating GPC-4 levels in serum and the corresponding MoCA score indicates a potential role of GPC-4 in PD-associated cognitive decline, which appears even more prominent in PD patients of older age. The gene discussed is GPC4; the disease is Parkinson disease.